HALOPERIDOL

HALOPERIDOL was reported 24939 times

HALOPERIDOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOCARDIAL REPERFUSION INJURY 18 0.4737
1 PAROXYSMAL PERCEPTUAL ALTERATION 27 0.4500
2 ENCEPHALITIS TOXIC 19 0.2405
3 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 158 0.2287
4 MALIGNANT CATATONIA 60 0.2281
5 DELUSION OF GRANDEUR 79 0.1759
6 REFUSAL OF EXAMINATION 21 0.1603
7 NEUROLEPTIC MALIGNANT SYNDROME 1646 0.1386
8 SPASMODIC DYSPHONIA 41 0.1353
9 WAXY FLEXIBILITY 22 0.1250
10 COGWHEEL RIGIDITY 104 0.0990
11 DISINHIBITION 153 0.0950
12 CATATONIA 442 0.0841
13 ECHOLALIA 25 0.0786
14 OSCILLOPSIA 18 0.0695
15 COLONIC PSEUDO-OBSTRUCTION 19 0.0681
16 OROMANDIBULAR DYSTONIA 49 0.0672
17 ANTICHOLINERGIC SYNDROME 105 0.0659
18 NEGLECT OF PERSONAL APPEARANCE 16 0.0658
19 BREATHING-RELATED SLEEP DISORDER 15 0.0633
20 FOETAL ARRHYTHMIA 15 0.0558
21 PSYCHOTIC SYMPTOM 115 0.0557
22 SCHIZOPHRENIA, PARANOID TYPE 20 0.0556
23 VISCERAL CONGESTION 28 0.0548
24 GRANDIOSITY 20 0.0546
25 RESTING TREMOR 35 0.0542
26 OCULOGYRIC CRISIS 111 0.0517
27 PROTRUSION TONGUE 30 0.0515
28 WATER INTOXICATION 26 0.0514
29 EXTRAPYRAMIDAL DISORDER 1253 0.0504
30 SCHIZOAFFECTIVE DISORDER 85 0.0476
31 DRUG-GENETIC INTERACTION 17 0.0476
32 EMOTIONAL POVERTY 83 0.0473
33 SEXUALLY INAPPROPRIATE BEHAVIOUR 22 0.0472
34 AKATHISIA 632 0.0463
35 LYMPHOCYTE COUNT ABNORMAL 52 0.0462
36 MUTISM 66 0.0454
37 PARKINSONIAN GAIT 28 0.0449
38 NEGATIVISM 33 0.0435
39 SCHIZOPHRENIA 525 0.0432
40 BLUNTED AFFECT 31 0.0420
41 BLOOD PROLACTIN ABNORMAL 36 0.0417
42 PARKINSONISM 407 0.0417
43 VERBAL ABUSE 20 0.0407
44 POSTURING 21 0.0404
45 MASKED FACIES 16 0.0394
46 HYPERPROLACTINAEMIA 255 0.0393
47 PERSECUTORY DELUSION 91 0.0365
48 NEPHROGENIC DIABETES INSIPIDUS 42 0.0364
49 TORTICOLLIS 77 0.0363
50 ENCEPHALITIS AUTOIMMUNE 46 0.0350
51 MUSCLE RIGIDITY 413 0.0345
52 HALLUCINATION, OLFACTORY 15 0.0345
53 PRIAPISM 116 0.0336
54 SALIVARY HYPERSECRETION 334 0.0334
55 DYSTONIA 637 0.0328
56 ANTIPSYCHOTIC DRUG LEVEL INCREASED 92 0.0326
57 THERAPEUTIC PRODUCT EFFECT VARIABLE 124 0.0319
58 SEDATION COMPLICATION 80 0.0313
59 METABOLIC SYNDROME 51 0.0310
60 BORDERLINE PERSONALITY DISORDER 22 0.0310
61 EMBOLISM VENOUS 89 0.0293
62 MULTIPLE DRUG THERAPY 22 0.0292
63 PSYCHOMOTOR RETARDATION 80 0.0284
64 HYPERREFLEXIA 98 0.0281
65 AUTONOMIC NERVOUS SYSTEM IMBALANCE 82 0.0280
66 OPISTHOTONUS 22 0.0277
67 APALLIC SYNDROME 20 0.0275
68 STUPOR 87 0.0271
69 HALLUCINATION, AUDITORY 430 0.0270
70 DELUSIONAL DISORDER, UNSPECIFIED TYPE 20 0.0267
71 CHOLINERGIC SYNDROME 17 0.0266
72 HYPERAMMONAEMIC ENCEPHALOPATHY 46 0.0264
73 HYPOPARATHYROIDISM 20 0.0261
74 ADENOMA BENIGN 22 0.0256
75 DELUSION 396 0.0255
76 RESPIRATORY ALKALOSIS 41 0.0252
77 OBSESSIVE-COMPULSIVE DISORDER 202 0.0251
78 SEDATION 649 0.0248
79 SYMPTOM MASKED 18 0.0247
80 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 22 0.0247
81 PRESSURE OF SPEECH 16 0.0246
82 TORSADE DE POINTES 193 0.0246
83 FEELING GUILTY 32 0.0242
84 ANOSOGNOSIA 18 0.0234
85 GRIMACING 18 0.0230
86 HYPORESPONSIVE TO STIMULI 27 0.0230
87 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 51 0.0228
88 ILEUS PARALYTIC 101 0.0226
89 DELIRIUM 779 0.0224
90 COMPULSIVE SEXUAL BEHAVIOUR 18 0.0222
91 CHOREA 38 0.0220
92 LIP EROSION 16 0.0219
93 DIET REFUSAL 16 0.0218
94 PSYCHOTIC DISORDER 640 0.0216
95 HYPOTHERMIA 219 0.0216
96 APRAXIA 32 0.0216
97 HYPERTHERMIA 163 0.0213
98 STEREOTYPY 20 0.0212
99 DYSLIPIDAEMIA 107 0.0210
100 NUCHAL RIGIDITY 19 0.0210
101 ELECTROCARDIOGRAM PR PROLONGATION 16 0.0209
102 DEMENTIA WITH LEWY BODIES 23 0.0207
103 CIRCADIAN RHYTHM SLEEP DISORDER 17 0.0205
104 REDUCED FACIAL EXPRESSION 20 0.0197
105 BRADYKINESIA 115 0.0195
106 PAROTITIS 22 0.0189
107 GAZE PALSY 32 0.0188
108 ELECTROCARDIOGRAM QT PROLONGED 672 0.0187
109 RHINALGIA 50 0.0182
110 ACUTE PSYCHOSIS 45 0.0182
111 POLYDIPSIA 71 0.0179
112 CLONUS 49 0.0179
113 TONIC CLONIC MOVEMENTS 23 0.0177
114 EUPHORIC MOOD 178 0.0174
115 CONSCIOUSNESS FLUCTUATING 18 0.0172
116 MYOCARDITIS 196 0.0171
117 PSYCHIATRIC DECOMPENSATION 33 0.0169
118 EOSINOPHIL COUNT DECREASED 40 0.0168
119 NEUTROPHIL COUNT INCREASED 172 0.0168
120 HYPERTONIA 96 0.0167
121 HEAD TITUBATION 23 0.0167
122 MEGACOLON 26 0.0165
123 DROOLING 113 0.0163
124 BLOOD PROLACTIN INCREASED 77 0.0163
125 VULVOVAGINAL CANDIDIASIS 22 0.0163
126 COMA SCALE ABNORMAL 47 0.0162
127 GRANULOCYTOPENIA 92 0.0161
128 SEROTONIN SYNDROME 306 0.0159
129 VICTIM OF CRIME 19 0.0154
130 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 26 0.0154
131 MYOCLONUS 183 0.0153
132 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 40 0.0153
133 LABILE BLOOD PRESSURE 18 0.0152
134 PSYCHOMOTOR HYPERACTIVITY 246 0.0148
135 HYPERTHERMIA MALIGNANT 22 0.0148
136 BLOOD CREATINE PHOSPHOKINASE INCREASED 421 0.0146
137 HALLUCINATIONS, MIXED 60 0.0143
138 AKINESIA 29 0.0140
139 SOCIAL AVOIDANT BEHAVIOUR 81 0.0140
140 URETERIC OBSTRUCTION 19 0.0139
141 DISTRACTIBILITY 16 0.0139
142 RESUSCITATION 23 0.0139
143 ELECTROENCEPHALOGRAM ABNORMAL 43 0.0136
144 INTESTINAL DILATATION 18 0.0135
145 TARDIVE DYSKINESIA 380 0.0135
146 MANIA 213 0.0129
147 ELECTROCARDIOGRAM T WAVE ABNORMAL 20 0.0128
148 BLOOD PHOSPHORUS DECREASED 46 0.0126
149 DRUG CLEARANCE DECREASED 16 0.0122
150 TROPONIN I INCREASED 20 0.0120
151 HYPERAMMONAEMIA 60 0.0120
152 AGITATION 881 0.0120
153 AFFECTIVE DISORDER 94 0.0119
154 SUDDEN CARDIAC DEATH 40 0.0117
155 AGGRESSION 586 0.0117
156 PITUITARY TUMOUR BENIGN 19 0.0116
157 HYPERNATRAEMIA 58 0.0116
158 PNEUMONIA ASPIRATION 290 0.0116
159 POSTURE ABNORMAL 37 0.0114
160 INAPPROPRIATE AFFECT 18 0.0113
161 RENAL NEOPLASM 24 0.0113
162 VENTRICULAR ARRHYTHMIA 41 0.0112
163 STARING 27 0.0112
164 SELF INJURIOUS BEHAVIOUR 34 0.0111
165 BLOOD BICARBONATE DECREASED 21 0.0111
166 REFUSAL OF TREATMENT BY PATIENT 72 0.0110
167 HOSTILITY 28 0.0110
168 HYPERKINESIA 23 0.0108
169 DRUG INTERACTION 1709 0.0108
170 DRUG LEVEL INCREASED 177 0.0107
171 METABOLIC DISORDER 62 0.0107
172 TONGUE BITING 22 0.0107
173 VENOUS THROMBOSIS LIMB 22 0.0107
174 PARADOXICAL DRUG REACTION 39 0.0106
175 FAECALOMA 58 0.0106
176 RHABDOMYOLYSIS 440 0.0105
177 BEHAVIOUR DISORDER 57 0.0105
178 COMMUNICATION DISORDER 40 0.0104
179 HYPERSEXUALITY 19 0.0104
180 IMPULSIVE BEHAVIOUR 39 0.0104
181 LEUKOCYTOSIS 188 0.0104
182 INCREASED APPETITE 198 0.0104
183 MENTAL IMPAIRMENT 251 0.0103
184 PARANOIA 178 0.0103
185 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 106 0.0103
186 HYPOTONIA NEONATAL 16 0.0102
187 THERAPEUTIC AGENT TOXICITY 34 0.0102
188 OBESITY 162 0.0102
189 RESTLESSNESS 370 0.0101
190 PARAPARESIS 18 0.0101
191 CEREBRAL ATROPHY 40 0.0100
192 BRAIN DEATH 31 0.0100
193 LONG QT SYNDROME 24 0.0100
194 ANTICONVULSANT DRUG LEVEL INCREASED 16 0.0099
195 HYPOREFLEXIA 19 0.0099
196 ALTERED STATE OF CONSCIOUSNESS 211 0.0097
197 DEPRESSED LEVEL OF CONSCIOUSNESS 384 0.0097
198 HYPERLACTACIDAEMIA 26 0.0097
199 TRISMUS 50 0.0097
200 ILLUSION 16 0.0097
201 DEPRESSIVE SYMPTOM 34 0.0096
202 SOPOR 127 0.0096
203 PANCREATITIS NECROTISING 22 0.0096
204 PHYSICAL ASSAULT 20 0.0096
205 SUICIDE ATTEMPT 579 0.0095
206 SUDDEN DEATH 99 0.0093
207 TIC 50 0.0092
208 HYPERCAPNIA 27 0.0090
209 DRUG MONITORING PROCEDURE NOT PERFORMED 16 0.0089
210 OBSESSIVE THOUGHTS 16 0.0089
211 VOLVULUS 21 0.0089
212 GESTATIONAL DIABETES 42 0.0088
213 SINUS BRADYCARDIA 85 0.0088
214 GALACTORRHOEA 56 0.0087
215 LEUKAEMIA 82 0.0087
216 LEUKOPENIA 434 0.0087
217 DYSKINESIA 352 0.0087
218 POTENTIATING DRUG INTERACTION 29 0.0086
219 TACHYPNOEA 117 0.0086
220 BLOOD SODIUM INCREASED 23 0.0085
221 SINUS TACHYCARDIA 121 0.0085
222 MENTAL STATUS CHANGES 231 0.0083
223 RESPIRATORY DEPRESSION 101 0.0082
224 INTENTIONAL SELF-INJURY 166 0.0082
225 DIABETIC COMA 23 0.0082
226 TREATMENT NONCOMPLIANCE 448 0.0082
227 COLITIS ISCHAEMIC 55 0.0081
228 RESPIRATORY ACIDOSIS 32 0.0081
229 HYPERVENTILATION 47 0.0081
230 VENTRICULAR FIBRILLATION 90 0.0081
231 BRAIN INJURY 81 0.0081
232 MIOSIS 64 0.0080
233 MUCOSAL DRYNESS 16 0.0079
234 ENCEPHALOPATHY 194 0.0079
235 EYE MOVEMENT DISORDER 54 0.0079
236 MUSCLE CONTRACTURE 16 0.0079
237 SELF-INJURIOUS IDEATION 33 0.0079
238 IMPAIRED SELF-CARE 16 0.0077
239 TOXIC EPIDERMAL NECROLYSIS 117 0.0077
240 MUSCLE CONTRACTIONS INVOLUNTARY 27 0.0077
241 LYMPHOCYTE COUNT INCREASED 25 0.0077
242 DRUG TOXICITY 103 0.0076
243 UNRESPONSIVE TO STIMULI 194 0.0075
244 KLEBSIELLA INFECTION 38 0.0075
245 ACCIDENTAL EXPOSURE 31 0.0074
246 SLOW SPEECH 18 0.0074
247 FEMORAL NECK FRACTURE 38 0.0074
248 DYSARTHRIA 277 0.0074
249 HYPOMANIA 27 0.0073
250 BIPOLAR I DISORDER 16 0.0073
251 PRESCRIBED OVERDOSE 141 0.0073
252 NEUROTOXICITY 127 0.0072
253 ELECTROCARDIOGRAM T WAVE INVERSION 16 0.0072
254 BRUXISM 39 0.0072
255 TENSION 44 0.0072
256 ASPIRATION 79 0.0072
257 HYPONATRAEMIA 405 0.0072
258 ENDOTRACHEAL INTUBATION 20 0.0071
259 TACHYCARDIA 633 0.0071
260 TROPONIN INCREASED 54 0.0071
261 LOGORRHOEA 25 0.0071
262 SELF-MEDICATION 29 0.0070
263 ABNORMAL BEHAVIOUR 277 0.0070
264 DRUG LEVEL ABOVE THERAPEUTIC 32 0.0070
265 BUNDLE BRANCH BLOCK RIGHT 32 0.0070
266 REBOUND EFFECT 78 0.0069
267 STAPHYLOCOCCAL SEPSIS 34 0.0069
268 PSYCHOMOTOR SKILLS IMPAIRED 18 0.0069
269 HYPOVENTILATION 22 0.0067
270 URINARY RETENTION 225 0.0067
271 PULSELESS ELECTRICAL ACTIVITY 28 0.0067
272 LYMPHOCYTE COUNT DECREASED 118 0.0067
273 BLOOD CHLORIDE DECREASED 17 0.0066
274 BRADYPHRENIA 43 0.0066
275 HAEMODYNAMIC INSTABILITY 50 0.0066
276 LEFT VENTRICULAR HYPERTROPHY 28 0.0065
277 POISONING 82 0.0065
278 GENERALISED TONIC-CLONIC SEIZURE 108 0.0065
279 FLAT AFFECT 15 0.0065
280 PENIS DISORDER 16 0.0065
281 CARDIAC DYSFUNCTION 24 0.0064
282 IMMOBILE 28 0.0064
283 DISORIENTATION 254 0.0064
284 NYSTAGMUS 34 0.0064
285 SUSPECTED SUICIDE 30 0.0064
286 VENTRICULAR HYPERTROPHY 16 0.0064
287 COMA 303 0.0064
288 NEPHROGENIC ANAEMIA 29 0.0063
289 PSYCHIATRIC SYMPTOM 46 0.0062
290 TOXICITY TO VARIOUS AGENTS 1049 0.0062
291 COGNITIVE DISORDER 290 0.0062
292 HALLUCINATION, VISUAL 131 0.0062
293 HOMICIDAL IDEATION 25 0.0062
294 BRONCHOPNEUMONIA 21 0.0061
295 WHITE BLOOD CELL COUNT INCREASED 235 0.0061
296 PERSONALITY DISORDER 16 0.0061
297 SEXUAL DYSFUNCTION 71 0.0060
298 APATHY 88 0.0060
299 HALLUCINATION 451 0.0060
300 ALCOHOL ABUSE 16 0.0060
301 DRUG LEVEL BELOW THERAPEUTIC 33 0.0060
302 TONGUE DISORDER 43 0.0059
303 DYSPHORIA 30 0.0059
304 BLOOD ALBUMIN DECREASED 47 0.0059
305 GAMBLING DISORDER 16 0.0059
306 BRADYCARDIA 314 0.0059
307 CARDIO-RESPIRATORY ARREST 247 0.0059
308 BUNDLE BRANCH BLOCK LEFT 25 0.0059
309 GASTROINTESTINAL NECROSIS 17 0.0058
310 WRONG PATIENT RECEIVED PRODUCT 17 0.0058
311 SCREAMING 37 0.0058
312 MONOCYTE COUNT INCREASED 21 0.0058
313 HYPERPHAGIA 23 0.0058
314 AZOTAEMIA 23 0.0058
315 AGRANULOCYTOSIS 107 0.0058
316 BRAIN OEDEMA 72 0.0057
317 ISCHAEMIA 26 0.0057
318 ORTHOPNOEA 18 0.0056
319 CACHEXIA 29 0.0056
320 BIPOLAR DISORDER 61 0.0056
321 DRUG RESISTANCE 142 0.0055
322 TACHYPHRENIA 19 0.0055
323 WEIGHT INCREASED 1227 0.0055
324 MAJOR DEPRESSION 40 0.0055
325 DYSPHEMIA 24 0.0055
326 COMPLETED SUICIDE 456 0.0055
327 VENTRICULAR TACHYCARDIA 90 0.0054
328 ENURESIS 22 0.0054
329 PERIORBITAL OEDEMA 28 0.0054
330 CARDIAC ARREST 437 0.0053
331 REBOUND ACID HYPERSECRETION 16 0.0053
332 INCOHERENT 34 0.0052
333 LEFT VENTRICULAR DYSFUNCTION 35 0.0052
334 BREAST ENLARGEMENT 17 0.0052
335 RESPIRATORY FAILURE 378 0.0052
336 ORTHOSTATIC HYPOTENSION 90 0.0052
337 CARDIOPULMONARY FAILURE 20 0.0051
338 HYPERTRIGLYCERIDAEMIA 30 0.0051
339 HYPOXIA 180 0.0051
340 VENTRICULAR EXTRASYSTOLES 53 0.0051
341 NEUTROPHILIA 29 0.0051
342 MULTIPLE DRUG OVERDOSE 25 0.0050
343 SNORING 19 0.0050
344 INCONTINENCE 53 0.0050
345 URINARY INCONTINENCE 148 0.0050
346 MYDRIASIS 64 0.0050
347 CYANOSIS 78 0.0050
348 TOXIC ENCEPHALOPATHY 25 0.0049
349 DYSCHEZIA 15 0.0049
350 PETIT MAL EPILEPSY 25 0.0049
351 DUODENITIS 15 0.0049
352 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16 0.0048
353 ACUTE PULMONARY OEDEMA 27 0.0048
354 THERAPY PARTIAL RESPONDER 75 0.0048
355 CARDIAC FAILURE ACUTE 32 0.0048
356 ATAXIA 57 0.0048
357 EOSINOPHIL COUNT INCREASED 40 0.0048
358 EATING DISORDER 102 0.0048
359 FIBRIN D DIMER INCREASED 17 0.0048
360 PROTEIN TOTAL DECREASED 18 0.0048
361 ASPHYXIA 39 0.0048
362 GRAND MAL CONVULSION 44 0.0048
363 CARDIOMYOPATHY 70 0.0047
364 PLATELET COUNT INCREASED 61 0.0047
365 CONFUSIONAL STATE 753 0.0047
366 TYPE 1 DIABETES MELLITUS 28 0.0046
367 INTENTIONAL OVERDOSE 297 0.0046
368 APNOEA 36 0.0046
369 THINKING ABNORMAL 86 0.0046
370 RESPIRATORY DISTRESS 127 0.0046
371 SUICIDAL BEHAVIOUR 19 0.0046
372 THROMBOPHLEBITIS 16 0.0046
373 ACUTE RESPIRATORY FAILURE 87 0.0045
374 OLIGURIA 28 0.0045
375 AMMONIA INCREASED 23 0.0045
376 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 17 0.0044
377 PHOTOPSIA 28 0.0044
378 PULSE ABSENT 21 0.0044
379 BLOOD TRIGLYCERIDES INCREASED 78 0.0044
380 ELECTROLYTE IMBALANCE 51 0.0044
381 NEUTROPHIL COUNT DECREASED 178 0.0044
382 ATRIOVENTRICULAR BLOCK COMPLETE 29 0.0043
383 POLYURIA 35 0.0043
384 ILEUS 53 0.0043
385 ATRIAL FLUTTER 34 0.0043
386 HYPERCHOLESTEROLAEMIA 41 0.0042
387 FAILURE TO THRIVE 22 0.0042
388 TREMOR 700 0.0042
389 LETHARGY 242 0.0042
390 SUICIDAL IDEATION 384 0.0042
391 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 40 0.0042
392 GASTRIC INFECTION 16 0.0042
393 MENTAL DISORDER 182 0.0042
394 SPEECH DISORDER 219 0.0042
395 SARS-COV-2 TEST POSITIVE 55 0.0042
396 THERAPY NON-RESPONDER 187 0.0042
397 MYOCARDIAL ISCHAEMIA 47 0.0041
398 METABOLIC ACIDOSIS 132 0.0041
399 BLOOD UREA INCREASED 69 0.0041
400 HYPOTONIA 41 0.0041
401 SOMNOLENCE 825 0.0041
402 C-REACTIVE PROTEIN INCREASED 149 0.0041
403 STEVENS-JOHNSON SYNDROME 91 0.0041
404 ELECTROCARDIOGRAM ABNORMAL 32 0.0041
405 CIRCULATORY COLLAPSE 69 0.0040
406 ENCEPHALITIS 28 0.0040
407 NEUTROPENIA 549 0.0040
408 HYPERTRANSAMINASAEMIA 28 0.0040
409 ODYNOPHAGIA 24 0.0040
410 HYPERPYREXIA 17 0.0040
411 MUSCLE TWITCHING 92 0.0040
412 EOSINOPHILIA 69 0.0039
413 EPILEPSY 120 0.0039
414 BODY TEMPERATURE INCREASED 80 0.0039
415 PULMONARY CONGESTION 51 0.0039
416 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 99 0.0038
417 HYPOKALAEMIA 177 0.0038
418 JAW DISORDER 21 0.0038
419 COORDINATION ABNORMAL 53 0.0038
420 DERMATITIS EXFOLIATIVE 19 0.0038
421 BLOOD LACTIC ACID INCREASED 20 0.0038
422 IRRITABILITY 228 0.0038
423 PULMONARY EMBOLISM 359 0.0038
424 RENAL TUBULAR NECROSIS 37 0.0038
425 DYSPHAGIA 357 0.0038
426 FOOD POISONING 20 0.0037
427 SUBSTANCE ABUSE 30 0.0037
428 BLOOD CHOLESTEROL ABNORMAL 17 0.0037
429 NORMAL NEWBORN 20 0.0037
430 UMBILICAL HERNIA 17 0.0036
431 INTESTINAL ISCHAEMIA 20 0.0036
432 RESPIRATORY RATE INCREASED 32 0.0036
433 DRUG ABUSE 299 0.0036
434 GLOMERULAR FILTRATION RATE DECREASED 44 0.0036
435 COVID-19 PNEUMONIA 42 0.0036
436 GENERAL PHYSICAL CONDITION ABNORMAL 24 0.0035
437 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 193 0.0035
438 MUCOSAL INFLAMMATION 92 0.0035
439 LUNG INFILTRATION 31 0.0035
440 WITHDRAWAL SYNDROME 147 0.0035
441 PSEUDOMONAS INFECTION 30 0.0035
442 CEREBRAL ISCHAEMIA 18 0.0035
443 DEMENTIA 97 0.0035
444 HAEMOLYTIC ANAEMIA 31 0.0035
445 PERICARDIAL EFFUSION 80 0.0035
446 HEPATOCELLULAR INJURY 49 0.0035
447 ACUTE RESPIRATORY DISTRESS SYNDROME 61 0.0034
448 DRUG LEVEL DECREASED 35 0.0034
449 MULTIPLE MYELOMA 16 0.0034
450 INFLAMMATORY MARKER INCREASED 17 0.0034
451 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 243 0.0034
452 RESPIRATORY ARREST 94 0.0034
453 HEPATITIS ACUTE 22 0.0034
454 ERYSIPELAS 17 0.0034
455 CHOKING 66 0.0034
456 HYPERGLYCAEMIA 123 0.0034
457 MOVEMENT DISORDER 108 0.0034
458 DISTURBANCE IN ATTENTION 180 0.0033
459 MOTOR DYSFUNCTION 34 0.0033
460 AFFECT LABILITY 32 0.0033
461 VARICOSE VEIN 17 0.0033
462 SEPTIC SHOCK 143 0.0033
463 POST-TRAUMATIC STRESS DISORDER 22 0.0033
464 RENAL CELL CARCINOMA 16 0.0033
465 ACUTE KIDNEY INJURY 498 0.0033
466 RENAL FAILURE ACUTE 138 0.0032
467 HYPOPHAGIA 83 0.0032
468 DIABETIC NEUROPATHY 16 0.0032
469 BLOOD ALKALINE PHOSPHATASE INCREASED 80 0.0032
470 HYPOALBUMINAEMIA 25 0.0032
471 GLUCOSE TOLERANCE IMPAIRED 19 0.0032
472 MULTIPLE ORGAN DYSFUNCTION SYNDROME 91 0.0032
473 DECUBITUS ULCER 26 0.0032
474 DIABETES MELLITUS 243 0.0032
475 TYPE 2 DIABETES MELLITUS 107 0.0032
476 DERMATITIS BULLOUS 23 0.0032
477 HAEMATOCRIT DECREASED 63 0.0032
478 HYPOKINESIA 46 0.0032
479 HYPOMAGNESAEMIA 44 0.0032
480 BLOOD LACTATE DEHYDROGENASE INCREASED 50 0.0032
481 GASTROENTERITIS 46 0.0031
482 CARDIOTOXICITY 28 0.0031
483 SHOCK 72 0.0031
484 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 16 0.0031
485 WRONG PRODUCT ADMINISTERED 21 0.0031
486 HEPATIC ENCEPHALOPATHY 29 0.0031
487 ASPARTATE AMINOTRANSFERASE INCREASED 165 0.0031
488 MEDICATION ERROR 172 0.0031
489 IMPAIRED GASTRIC EMPTYING 42 0.0031
490 ABNORMAL WEIGHT GAIN 38 0.0031
491 ACUTE HEPATIC FAILURE 42 0.0031
492 HYDRONEPHROSIS 23 0.0031
493 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 23 0.0031
494 RASH MACULO-PAPULAR 68 0.0031
495 NERVOUS SYSTEM DISORDER 95 0.0030
496 ANGIOPATHY 17 0.0030
497 SEIZURE 350 0.0030
498 RESTLESS LEGS SYNDROME 55 0.0030
499 BLOOD SODIUM DECREASED 57 0.0030
500 RENAL CYST 24 0.0030
501 END STAGE RENAL DISEASE 55 0.0030
502 BLOOD CREATININE INCREASED 196 0.0030
503 ORAL DISORDER 22 0.0030
504 ARRHYTHMIA 142 0.0030
505 FLUID INTAKE REDUCED 15 0.0030
506 DISSEMINATED INTRAVASCULAR COAGULATION 42 0.0030
507 HAEMODIALYSIS 25 0.0030
508 ATRIOVENTRICULAR BLOCK 23 0.0030
509 LIVER FUNCTION TEST ABNORMAL 86 0.0030
510 ALANINE AMINOTRANSFERASE INCREASED 181 0.0029
511 NEUTROPENIC SEPSIS 21 0.0029
512 UROSEPSIS 27 0.0029
513 TRANSAMINASES INCREASED 65 0.0029
514 AMENORRHOEA 51 0.0029
515 ATELECTASIS 28 0.0029
516 TUBULOINTERSTITIAL NEPHRITIS 54 0.0029
517 DISSOCIATION 22 0.0029
518 HYPOTENSION 575 0.0029
519 HYPOGLYCAEMIA 138 0.0028
520 PRODUCT PACKAGING ISSUE 27 0.0028
521 PERICARDITIS 47 0.0028
522 NO THERAPEUTIC RESPONSE 34 0.0028
523 CARDIOGENIC SHOCK 40 0.0028
524 SWOLLEN TONGUE 87 0.0028
525 GENERAL PHYSICAL HEALTH DETERIORATION 318 0.0027
526 CLOSTRIDIUM DIFFICILE COLITIS 29 0.0027
527 PURPURA 24 0.0027
528 DIABETIC KETOACIDOSIS 65 0.0027
529 CONDITION AGGRAVATED 821 0.0027
530 SEPSIS 299 0.0027
531 HYPERLIPIDAEMIA 32 0.0027
532 MUSCULOSKELETAL STIFFNESS 232 0.0026
533 DRUG DISPENSING ERROR 40 0.0026
534 HYPERHIDROSIS 337 0.0026
535 LOSS OF CONSCIOUSNESS 334 0.0026
536 CONVULSION 149 0.0026
537 THROMBOCYTOPENIA 289 0.0026
538 ANURIA 22 0.0026
539 GAMMA-GLUTAMYLTRANSFERASE INCREASED 56 0.0025
540 URINE OUTPUT DECREASED 22 0.0025
541 MALNUTRITION 28 0.0025
542 STATUS EPILEPTICUS 28 0.0025
543 FOETAL GROWTH RESTRICTION 15 0.0025
544 JOINT DISLOCATION 26 0.0025
545 ERECTILE DYSFUNCTION 63 0.0025
546 BODY TEMPERATURE DECREASED 24 0.0024
547 BLOOD MAGNESIUM DECREASED 21 0.0024
548 CEREBRAL DISORDER 18 0.0024
549 HEPATIC CYTOLYSIS 31 0.0024
550 HAEMATEMESIS 61 0.0024
551 METASTASES TO CENTRAL NERVOUS SYSTEM 31 0.0024
552 LOW BIRTH WEIGHT BABY 19 0.0024
553 DEPRESSED MOOD 126 0.0024
554 TOXIC SKIN ERUPTION 24 0.0024
555 HYPOTHYROIDISM 76 0.0024
556 HYPOCALCAEMIA 45 0.0024
557 CONJUNCTIVITIS 44 0.0024
558 WHITE BLOOD CELL COUNT DECREASED 257 0.0024
559 PERSONALITY CHANGE 22 0.0024
560 PYREXIA 817 0.0024
561 OVERDOSE 509 0.0024
562 HYPERCALCAEMIA 29 0.0023
563 MATERNAL EXPOSURE BEFORE PREGNANCY 16 0.0023
564 MYOPATHY 20 0.0023
565 PELVIC FRACTURE 18 0.0023
566 HYPERSOMNIA 66 0.0023
567 HEMIPARESIS 39 0.0023
568 SPINAL COMPRESSION FRACTURE 19 0.0023
569 ACUTE CORONARY SYNDROME 19 0.0023
570 PRODUCT ADMINISTRATION INTERRUPTED 18 0.0023
571 RENAL FAILURE 303 0.0023
572 ORAL CANDIDIASIS 30 0.0023
573 PANCREATITIS ACUTE 51 0.0023
574 CELLULITIS 113 0.0022
575 EYELID OEDEMA 26 0.0022
576 FEAR 60 0.0022
577 ACIDOSIS 17 0.0022
578 ANAL INCONTINENCE 20 0.0022
579 TREATMENT FAILURE 183 0.0022
580 MITRAL VALVE INCOMPETENCE 25 0.0022
581 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 15 0.0022
582 LOWER RESPIRATORY TRACT INFECTION 100 0.0022
583 MULTI-ORGAN FAILURE 38 0.0022
584 SUPRAVENTRICULAR TACHYCARDIA 21 0.0022
585 PULMONARY OEDEMA 98 0.0022
586 PLEURAL EFFUSION 133 0.0022
587 ECONOMIC PROBLEM 33 0.0022
588 HYPERKALAEMIA 76 0.0022
589 ACCIDENTAL OVERDOSE 79 0.0022
590 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 37 0.0022
591 DRUG SCREEN POSITIVE 17 0.0021
592 EXTRASYSTOLES 15 0.0021
593 RENAL IMPAIRMENT 180 0.0021
594 CHOLESTASIS 41 0.0021
595 HYPERTENSION 450 0.0021
596 BLOOD DISORDER 17 0.0021
597 FACIAL PARALYSIS 18 0.0021
598 HEPATOTOXICITY 47 0.0021
599 RESPIRATORY DISORDER 63 0.0021
600 MUSCLE TIGHTNESS 34 0.0021
601 HEPATIC STEATOSIS 39 0.0021
602 PRODUCT USE IN UNAPPROVED INDICATION 517 0.0021
603 RENAL FAILURE CHRONIC 16 0.0021
604 METASTASES TO LUNG 24 0.0021
605 HYPERTHYROIDISM 30 0.0021
606 PLATELET COUNT DECREASED 219 0.0021
607 LYMPHOPENIA 29 0.0020
608 SKIN INFECTION 23 0.0020
609 NEPHROPATHY TOXIC 23 0.0020
610 CHRONIC KIDNEY DISEASE 155 0.0020
611 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 18 0.0020
612 INTERNATIONAL NORMALISED RATIO INCREASED 58 0.0020
613 THERAPY CHANGE 20 0.0020
614 APHASIA 61 0.0020
615 GASTRITIS 53 0.0020
616 AMNESIA 131 0.0020
617 EMOTIONAL DISORDER 62 0.0020
618 CONSTIPATION 437 0.0020
619 SPUTUM DISCOLOURED 19 0.0020
620 EJECTION FRACTION DECREASED 31 0.0020
621 CARDIAC FAILURE 160 0.0020
622 ANXIETY 562 0.0020
623 EXPOSURE DURING PREGNANCY 122 0.0020
624 DRUG WITHDRAWAL SYNDROME 171 0.0019
625 SLEEP DISORDER 137 0.0019
626 ANOREXIA 25 0.0019
627 HOSPICE CARE 19 0.0019
628 OXYGEN SATURATION DECREASED 108 0.0019
629 LIVE BIRTH 16 0.0019
630 PALLOR 52 0.0019
631 BLOOD POTASSIUM INCREASED 31 0.0019
632 GYNAECOMASTIA 59 0.0019
633 ACUTE MYOCARDIAL INFARCTION 56 0.0019
634 CAESAREAN SECTION 22 0.0019
635 RED BLOOD CELL COUNT DECREASED 54 0.0019
636 PRODUCT ADMINISTRATION ERROR 38 0.0019
637 HEPATITIS 48 0.0019
638 INTENTIONAL PRODUCT MISUSE 163 0.0019
639 BLOOD TEST ABNORMAL 26 0.0018
640 PYELONEPHRITIS 16 0.0018
641 UPPER GASTROINTESTINAL HAEMORRHAGE 31 0.0018
642 HYPERBILIRUBINAEMIA 19 0.0018
643 HEPATOMEGALY 18 0.0018
644 ANHEDONIA 48 0.0018
645 DRUG WITHDRAWAL SYNDROME NEONATAL 27 0.0018
646 ANGIOEDEMA 80 0.0018
647 EMBOLISM 15 0.0018
648 ASCITES 53 0.0018
649 HYPERTENSIVE CRISIS 20 0.0018
650 FRACTURE 34 0.0018
651 APHONIA 25 0.0018
652 CARDIOMEGALY 22 0.0018
653 CONTRAINDICATED PRODUCT ADMINISTERED 54 0.0018
654 RETCHING 38 0.0018
655 PNEUMONIA 577 0.0018
656 BLOOD CALCIUM DECREASED 20 0.0018
657 INTESTINAL OBSTRUCTION 67 0.0018
658 GENERALISED OEDEMA 22 0.0018
659 PANCYTOPENIA 99 0.0018
660 DEEP VEIN THROMBOSIS 115 0.0018
661 INSOMNIA 471 0.0018
662 DIABETES MELLITUS INADEQUATE CONTROL 31 0.0017
663 BEDRIDDEN 23 0.0017
664 PARALYSIS 25 0.0017
665 NOCTURIA 21 0.0017
666 FOETAL EXPOSURE DURING PREGNANCY 140 0.0017
667 ANGER 58 0.0017
668 HEPATIC FUNCTION ABNORMAL 64 0.0017
669 SYNCOPE 171 0.0017
670 SPLENOMEGALY 20 0.0017
671 PNEUMOTHORAX 27 0.0017
672 ARTERIOSCLEROSIS 16 0.0017
673 BLOOD POTASSIUM DECREASED 51 0.0017
674 PREMATURE BABY 51 0.0017
675 DRUG ERUPTION 30 0.0017
676 POISONING DELIBERATE 16 0.0017
677 EMPHYSEMA 17 0.0017
678 ATRIAL FIBRILLATION 164 0.0017
679 SLEEP APNOEA SYNDROME 32 0.0017
680 SUBDURAL HAEMATOMA 24 0.0017
681 SLUGGISHNESS 17 0.0017
682 HAEMOGLOBIN DECREASED 171 0.0017
683 DRUG INEFFECTIVE 2184 0.0017
684 RESPIRATORY TRACT INFECTION 43 0.0016
685 BLOOD PRESSURE DECREASED 109 0.0016
686 OFF LABEL USE 1426 0.0016
687 FEBRILE NEUTROPENIA 108 0.0016
688 DEHYDRATION 217 0.0016
689 SMALL INTESTINAL OBSTRUCTION 20 0.0016
690 DEPRESSION 369 0.0016
691 BLISTER 91 0.0016
692 MATERNAL EXPOSURE DURING PREGNANCY 144 0.0016
693 STAPHYLOCOCCAL INFECTION 53 0.0016
694 FALL 534 0.0016
695 BLOOD BILIRUBIN INCREASED 43 0.0016
696 BLOOD CHOLESTEROL INCREASED 74 0.0016
697 LYMPHADENOPATHY 56 0.0016
698 LACTIC ACIDOSIS 51 0.0016
699 SUBARACHNOID HAEMORRHAGE 16 0.0016
700 OEDEMA PERIPHERAL 191 0.0016
701 INITIAL INSOMNIA 16 0.0016
702 NEOPLASM PROGRESSION 54 0.0016
703 VOMITING 727 0.0015
704 CANDIDA INFECTION 26 0.0015
705 ABASIA 38 0.0015
706 THERAPEUTIC RESPONSE DECREASED 93 0.0015
707 PETECHIAE 16 0.0015
708 CENTRAL NERVOUS SYSTEM LESION 21 0.0015
709 NEURALGIA 37 0.0015
710 BLOOD IRON DECREASED 18 0.0015
711 DRUG INTOLERANCE 146 0.0015
712 CHOLECYSTITIS 18 0.0015
713 GAIT DISTURBANCE 288 0.0015
714 DRUG-INDUCED LIVER INJURY 47 0.0015
715 CYTOKINE RELEASE SYNDROME 30 0.0015
716 NEUROPATHY PERIPHERAL 142 0.0015
717 DECREASED ACTIVITY 16 0.0015
718 NIGHTMARE 51 0.0015
719 MOOD ALTERED 40 0.0015
720 HEPATIC FAILURE 44 0.0015
721 HEAD INJURY 46 0.0015
722 PERITONITIS 30 0.0014
723 DENTAL CARIES 16 0.0014
724 COAGULOPATHY 24 0.0014
725 BLOOD PRESSURE SYSTOLIC INCREASED 28 0.0014
726 BACTERAEMIA 17 0.0014
727 ANGINA PECTORIS 41 0.0014
728 MOUTH ULCERATION 30 0.0014
729 FACE OEDEMA 24 0.0014
730 POOR QUALITY SLEEP 30 0.0014
731 DYSURIA 51 0.0014
732 LIVER INJURY 34 0.0014
733 URINARY TRACT INFECTION 236 0.0014
734 DYSSTASIA 40 0.0014
735 DEVICE RELATED INFECTION 21 0.0014
736 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 71 0.0014
737 HEART RATE INCREASED 134 0.0014
738 HAEMATURIA 46 0.0013
739 CHOLELITHIASIS 44 0.0013
740 DIALYSIS 19 0.0013
741 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 64 0.0013
742 ABDOMINAL PAIN 307 0.0013
743 DISEASE PROGRESSION 155 0.0013
744 ANAEMIA 249 0.0013
745 DISEASE RECURRENCE 62 0.0013
746 JAUNDICE 35 0.0013
747 THIRST 23 0.0013
748 HEART RATE IRREGULAR 29 0.0013
749 BONE MARROW FAILURE 26 0.0013
750 PRODUCTIVE COUGH 61 0.0013
751 SKIN LESION 35 0.0013
752 HOSPITALISATION 196 0.0013
753 HYPOAESTHESIA ORAL 19 0.0013
754 INCORRECT ROUTE OF DRUG ADMINISTRATION 45 0.0013
755 ACCIDENT 15 0.0013
756 VISION BLURRED 172 0.0013
757 HEPATITIS C 15 0.0012
758 DRUG EXPOSURE DURING PREGNANCY 42 0.0012
759 BALANCE DISORDER 106 0.0012
760 HUNGER 17 0.0012
761 LIVER DISORDER 54 0.0012
762 MEMORY IMPAIRMENT 167 0.0012
763 ACTIVITIES OF DAILY LIVING IMPAIRED 24 0.0012
764 RECTAL HAEMORRHAGE 52 0.0012
765 DRY MOUTH 96 0.0012
766 BACTERIAL INFECTION 22 0.0012
767 HAEMORRHOIDS 23 0.0012
768 PANCREATITIS 62 0.0012
769 MUSCULOSKELETAL CHEST PAIN 18 0.0012
770 DECREASED APPETITE 270 0.0012
771 MULTIPLE FRACTURES 19 0.0012
772 RENAL DISORDER 53 0.0011
773 COLITIS 43 0.0011
774 ABSCESS 18 0.0011
775 BRONCHOSPASM 16 0.0011
776 LIVER FUNCTION TEST INCREASED 24 0.0011
777 OEDEMA 60 0.0011
778 PNEUMONITIS 30 0.0011
779 HEPATIC ENZYME INCREASED 75 0.0011
780 METASTASES TO BONE 18 0.0011
781 ACUTE MYELOID LEUKAEMIA 17 0.0011
782 HIP FRACTURE 35 0.0011
783 BLOOD GLUCOSE ABNORMAL 20 0.0011
784 COLD SWEAT 19 0.0011
785 HEAD DISCOMFORT 19 0.0011
786 ISCHAEMIC STROKE 19 0.0011
787 CARDIOVASCULAR DISORDER 27 0.0011
788 TOOTH LOSS 22 0.0011
789 RASH MACULAR 37 0.0011
790 ADVERSE DRUG REACTION 95 0.0011
791 GASTROINTESTINAL HAEMORRHAGE 88 0.0011
792 CHEST PAIN 194 0.0010
793 PANIC ATTACK 38 0.0010
794 DYSPEPSIA 102 0.0010
795 COMPLICATION ASSOCIATED WITH DEVICE 15 0.0010
796 JOINT STIFFNESS 27 0.0010
797 ABDOMINAL PAIN LOWER 26 0.0010
798 BASAL CELL CARCINOMA 16 0.0010
799 WEIGHT DECREASED 286 0.0010
800 INFECTION 147 0.0010
801 NERVOUSNESS 53 0.0010
802 MALAISE 443 0.0010
803 PRODUCT PRESCRIBING ISSUE 22 0.0010
804 TRANSIENT ISCHAEMIC ATTACK 34 0.0010
805 BLINDNESS 41 0.0010
806 RASH GENERALISED 26 0.0010
807 MOOD SWINGS 32 0.0010
808 DRUG EFFECT INCOMPLETE 36 0.0010
809 MALIGNANT NEOPLASM PROGRESSION 101 0.0010
810 CEREBRAL INFARCTION 24 0.0010
811 RENAL INJURY 29 0.0010
812 METASTASES TO LIVER 17 0.0010
813 DYSPNOEA 545 0.0010
814 PULMONARY HYPERTENSION 20 0.0010
815 LUNG DISORDER 47 0.0010
816 INTENTIONAL DRUG MISUSE 20 0.0010
817 MELAENA 21 0.0010
818 ADVERSE EVENT 87 0.0009
819 FULL BLOOD COUNT DECREASED 19 0.0009
820 FEMUR FRACTURE 29 0.0009
821 ASTHENIA 352 0.0009
822 POLLAKIURIA 39 0.0009
823 UPPER RESPIRATORY TRACT INFECTION 43 0.0009
824 GASTROINTESTINAL DISORDER 83 0.0009
825 CHILLS 108 0.0009
826 LOCAL SWELLING 16 0.0009
827 CYSTITIS 29 0.0009
828 ABDOMINAL DISTENSION 95 0.0009
829 INTERSTITIAL LUNG DISEASE 44 0.0009
830 ANAPHYLACTIC REACTION 50 0.0009
831 PRESCRIBED UNDERDOSE 18 0.0009
832 GASTRIC ULCER 17 0.0009
833 GASTROOESOPHAGEAL REFLUX DISEASE 72 0.0009
834 INFLAMMATION 46 0.0009
835 DRUG EFFECT DECREASED 48 0.0009
836 POST PROCEDURAL COMPLICATION 17 0.0009
837 ROAD TRAFFIC ACCIDENT 37 0.0009
838 BONE DISORDER 16 0.0009
839 DIARRHOEA 566 0.0009
840 MOBILITY DECREASED 63 0.0009
841 OSTEOARTHRITIS 37 0.0009
842 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
843 VIRAL INFECTION 29 0.0009
844 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
845 GAIT INABILITY 29 0.0009
846 NAUSEA 674 0.0009
847 HEPATIC CIRRHOSIS 16 0.0009
848 DYSPNOEA EXERTIONAL 32 0.0008
849 PLASMA CELL MYELOMA 33 0.0008
850 CARDIAC DISORDER 79 0.0008
851 INTENTIONAL DOSE OMISSION 24 0.0008
852 CHROMATURIA 19 0.0008
853 DEATH 725 0.0008
854 RHINORRHOEA 54 0.0008
855 BLOOD PRESSURE FLUCTUATION 20 0.0008
856 TINNITUS 38 0.0008
857 EMOTIONAL DISTRESS 100 0.0008
858 HEART RATE DECREASED 29 0.0008
859 CRYING 30 0.0008
860 COVID-19 144 0.0008
861 PRODUCT USE ISSUE 154 0.0008
862 THERAPY CESSATION 42 0.0008
863 KIDNEY INFECTION 16 0.0008
864 SKIN ULCER 21 0.0008
865 CEREBRAL HAEMORRHAGE 29 0.0008
866 VISUAL IMPAIRMENT 99 0.0008
867 MUSCULAR WEAKNESS 90 0.0008
868 BLOOD URINE PRESENT 15 0.0008
869 HAEMOPTYSIS 22 0.0008
870 FEELING JITTERY 15 0.0008
871 FAECES DISCOLOURED 17 0.0008
872 SWELLING FACE 51 0.0008
873 DRUG ADMINISTRATION ERROR 24 0.0008
874 RIB FRACTURE 16 0.0008
875 CORONARY ARTERY DISEASE 23 0.0008
876 MYALGIA 129 0.0008
877 BLOOD PRESSURE INCREASED 116 0.0008
878 OCULAR HYPERAEMIA 36 0.0008
879 DISABILITY 15 0.0008
880 INJURY 52 0.0007
881 ANAPHYLACTIC SHOCK 19 0.0007
882 BLOOD GLUCOSE INCREASED 138 0.0007
883 RASH ERYTHEMATOUS 35 0.0007
884 DIPLOPIA 19 0.0007
885 EYE DISORDER 24 0.0007
886 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
887 NECK PAIN 40 0.0007
888 WOUND 20 0.0007
889 DIZZINESS 356 0.0007
890 PRODUCT PRESCRIBING ERROR 17 0.0007
891 WHEEZING 42 0.0007
892 MUSCLE SPASMS 129 0.0007
893 INTENTIONAL PRODUCT USE ISSUE 61 0.0007
894 LACRIMATION INCREASED 21 0.0007
895 FEELING ABNORMAL 166 0.0007
896 PALPITATIONS 81 0.0007
897 LIP SWELLING 23 0.0007
898 FATIGUE 537 0.0007
899 CEREBROVASCULAR ACCIDENT 116 0.0007
900 ABORTION SPONTANEOUS 27 0.0007
901 OROPHARYNGEAL PAIN 62 0.0007
902 ALOPECIA 128 0.0007
903 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19 0.0006
904 INCORRECT DOSE ADMINISTERED 148 0.0006
905 FEELING HOT 39 0.0006
906 DYSPHONIA 37 0.0006
907 OSTEOPOROSIS 26 0.0006
908 THERAPEUTIC PRODUCT EFFECT DECREASED 28 0.0006
909 MYOCARDIAL INFARCTION 109 0.0006
910 COUGH 175 0.0006
911 PERIPHERAL SWELLING 94 0.0006
912 HYPERSENSITIVITY 113 0.0006
913 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22 0.0006
914 CATARACT 36 0.0006
915 CONTUSION 58 0.0006
916 EPISTAXIS 45 0.0006
917 VERTIGO 36 0.0006
918 DISCOMFORT 36 0.0006
919 FLATULENCE 33 0.0006
920 HAEMATOMA 15 0.0006
921 STOMATITIS 34 0.0006
922 THERAPEUTIC RESPONSE UNEXPECTED 25 0.0006
923 CARDIAC FAILURE CONGESTIVE 44 0.0005
924 MIGRAINE 52 0.0005
925 ABNORMAL DREAMS 15 0.0005
926 UNEVALUABLE EVENT 41 0.0005
927 FEELING COLD 15 0.0005
928 SKIN EXFOLIATION 45 0.0005
929 ABDOMINAL PAIN UPPER 109 0.0005
930 HAEMATOCHEZIA 29 0.0005
931 FLUID RETENTION 26 0.0005
932 SKIN DISORDER 17 0.0005
933 THROMBOSIS 41 0.0005
934 HYPOAESTHESIA 74 0.0005
935 BACK PAIN 113 0.0005
936 PAIN 296 0.0005
937 PRURITUS 183 0.0005
938 HEADACHE 297 0.0005
939 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16 0.0005
940 CHEST DISCOMFORT 48 0.0005
941 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 33 0.0005
942 LUNG NEOPLASM MALIGNANT 19 0.0005
943 ACNE 35 0.0005
944 SURGERY 27 0.0005
945 EYE SWELLING 17 0.0005
946 ERYTHEMA 93 0.0005
947 RASH 195 0.0004
948 HOT FLUSH 33 0.0004
949 ABDOMINAL DISCOMFORT 72 0.0004
950 ILL-DEFINED DISORDER 26 0.0004
951 BONE PAIN 25 0.0004
952 INFLUENZA LIKE ILLNESS 35 0.0004
953 MUSCULOSKELETAL PAIN 22 0.0004
954 NEOPLASM MALIGNANT 28 0.0004
955 BRONCHITIS 31 0.0004
956 DRUG DEPENDENCE 67 0.0004
957 HAEMORRHAGE 43 0.0004
958 PRODUCT SUBSTITUTION ISSUE 23 0.0004
959 BLOOD GLUCOSE DECREASED 19 0.0004
960 SWELLING 37 0.0004
961 ARTHRITIS 31 0.0004
962 PARAESTHESIA 61 0.0004
963 ECZEMA 20 0.0004
964 NEPHROLITHIASIS 17 0.0004
965 RASH PRURITIC 20 0.0004
966 ARTHROPATHY 20 0.0004
967 SKIN DISCOLOURATION 16 0.0003
968 JOINT SWELLING 42 0.0003
969 PAIN IN EXTREMITY 101 0.0003
970 UNDERDOSE 25 0.0003
971 FLUSHING 34 0.0003
972 INFLUENZA 37 0.0003
973 PRODUCT DOSE OMISSION 20 0.0003
974 DRY EYE 15 0.0003
975 THERAPY INTERRUPTED 21 0.0003
976 NASOPHARYNGITIS 53 0.0003
977 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 51 0.0003
978 ARTHRALGIA 117 0.0003
979 DRUG DOSE OMISSION 46 0.0003
980 BREAST CANCER 25 0.0003
981 ASTHMA 30 0.0003
982 NO ADVERSE EVENT 48 0.0003
983 PRODUCT QUALITY ISSUE 35 0.0003
984 BURNING SENSATION 17 0.0002
985 ACCIDENTAL EXPOSURE TO PRODUCT 24 0.0002
986 PRODUCT DOSE OMISSION ISSUE 67 0.0002
987 URTICARIA 38 0.0002
988 DYSGEUSIA 16 0.0002
989 PSORIASIS 27 0.0002
990 ILLNESS 21 0.0002
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
992 SINUSITIS 17 0.0002
993 DRY SKIN 20 0.0001
994 INJECTION SITE PAIN 38 0.0001